Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, and SofPulse Electroceutical Therapy. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Endonovo Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Endonovo Therapeutics Inc market cap is $31,900.00.
What is the 52-week high for Endonovo Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Endonovo Therapeutics Inc 52 week high is $0.0016 as of October 10, 2025.
What is the 52-week low for Endonovo Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Endonovo Therapeutics Inc 52 week low is $0.00 as of October 10, 2025.
What is Endonovo Therapeutics Inc stock price today?
Endonovo Therapeutics Inc stock price today is $0.0001.
What was Endonovo Therapeutics Inc stock price yesterday?
Endonovo Therapeutics Inc stock price yesterday was $0.0001.
What is the PE ratio of Endonovo Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Endonovo Therapeutics Inc’s P/E ratio is -0.02.
What is the Price-to-Book ratio of Endonovo Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Endonovo Therapeutics Inc P/B ratio is -0.0040.
What is the 50-day moving average of Endonovo Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Endonovo Therapeutics Inc 50-day moving average is $0.0001.